Dietary isoflavones and gastric cancer: A brief review of current studies

Journal of Research in Medical Sciences

Volumn 20, Issue 9, 2015, Pages 893-900

  Golpour, Asahar ^a,b   Rafie, Nahid ^a,b   Safavi, Seyyed Morteza ^a,b   Miraghajani, Maryam ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dietary isoflavones; Flavonoids; Gastric cancer

Indexed keywords

ISOFLAVONE;

AGE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; DIETARY INTAKE; DISEASE ASSOCIATION; ETHNICITY; GENDER; HUMAN; REVIEW; STOMACH CANCER;

EID: 84948763907     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: 10.4103/1735-1995.170627     Document Type: Review

References (38)

1. Yang Y, Liu J, Li X, Li JC. PCDH17 gene promoter demethylation and cell cycle arrest by genistein in gastric cancer. Histol Histopathol 2012;27:217-24.
2. Hara A, Sasazuki S, Inoue M, Iwasaki M, Shimazu T, Sawada N, et al. Isoflavone intake and risk of gastric cancer: A populationbased prospective cohort study in Japan. Am J Clin Nutr 2012;95:147-54.
3. Hara A, Sasazuki S, Inoue M, Miura T, Iwasaki M, Sawada N, et al. Plasma isoflavone concentrations are not associated with gastric cancer risk among Japanese men and women. J Nutr 2013;143:1293-8.
4. Ko KP, Park SK, Park B, Yang JJ, Cho LY, Kang C, et al. Isoflavones from phytoestrogens and gastric cancer risk: A nested case-control study within the Korean Multicenter Cancer Cohort. Cancer Epidemiol Biomarkers Prev 2010;19:1292-300.
5. Lin LZ, He XG, Lindenmaier M, Yang J, Cleary M, Qiu SX, et al. LC-ESI-MS study of the flavonoid glycoside malonates of red clover (Trifolium pratense). J Agric Food Chem 2000;48:354-65.
6. Murkies AL, Wilcox G, Davis SR. Clinical review 92: Phytoestrogens. J Clin Endocrinol Metab 1998;83:297-303.
7. Reiter E, Gerster P, Jungbauer A. Red clover and soy isoflavones - an in vitro safety assessment. Gynecol Endocrinol 2011;27:1037-42.
8. Sugiyama Y, Masumori N, Fukuta F, Yoneta A, Hida T, Yamashita T, et al. Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk. Asian Pac J Cancer Prev 2013;14:1-4.
9. Yuan JP, Wang JH, Liu X. Metabolism of dietary soy isoflavones to equol by human intestinal microflora — implications for health. Mol Nutr Food Res 2007;51:765-81.
10. Qu XL, Fang Y, Zhang M, Zhang YZ. Phytoestrogen intake and risk of ovarian cancer: Ameta-analysis of 10 observational studies. Asian Pac J Cancer Prev 2014;15:9085-91.
11. Nagata C, Takatsuka N, Kawakami N, Shimizu H. A prospective cohort study of soy product intake and stomach cancer death. Br J Cancer 2002;87:31-6.
12. Kweon SS, Shu XO, Xiang Y, Cai H, Yang G, Ji BT, et al. Intake of specific nonfermented soy foods may be inversely associated with risk of distal gastric cancer in a Chinese population. J Nutr 2013;143:1736-42.
13. Ashtari S and Vahedi M. Economic burden of gastrointestinal cancer: Estimation and importance. Transl Gastrointest Cancer 2014;3:178-81.
14. Chun OK, Chung SJ, Song WO. Urinary isoflavones and their metabolites validate the dietary isoflavone intakes in US adults. J Am Diet Assoc 2009;109:245-54.
15. van Duursen MB, Nijmeijer SM, de Morree ES, de Jong PC, van den Berg M. Genistein induces breast cancer-associated aromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model. Toxicology 2011;289:67-73.
16. Chen J, Zeng J, Xin M, Huang W, Chen X. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo. Horm Metab Res 2011;43:681-6.
17. Morito K, Aomori T, Hirose T, Kinjo J, Hasegawa J, Ogawa S, et al. Interaction of phytoestrogens with estrogen receptors alpha and beta (II). Biol Pharm Bull 2002;25:48-52.
18. Rajah TT, Du N, Drews N, Cohn R. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells. Pharmacology 2009;84:68-73.
19. Wells G, Shea B, O’connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Clinical Epidemiology Unit, University of Ottawa; 2000.
20. Lagiou P, Samoli E, Lagiou A, Peterson J, Tzonou A, Dwyer J, et al. Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes Control 2004;15:67-72.
21. Nomura AM, Hankin JH, Kolonel LN, Wilkens LR, Goodman MT, Stemmermann GN. Case-control study of diet and other risk factors for gastric cancer in Hawaii (United States). Cancer Causes Control 2003;14:547-58.
22. Woo HD, Lee J, Choi IJ, Kim CG, Lee JY, Kwon O, et al. Dietary flavonoids and gastric cancer risk in a Korean population. Nutrients 2014;6:4961-73.
23. Nagata C. Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan. Int J Epidemiol 2000;29:832-6.
24. Adlercreutz H. Phytooestrogens and cancer. Lancet Oncol 2002;3:364-73.
25. Warri A, Saarinen NM, Makela S, Hilakivi-Clarke L. The role of early life genistein exposures in modifying breast cancer risk. Br J Cancer 2008;98:1485-93.
26. Yanagihara K, Ito A, Toge T, Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 1993;53:5815-21.
27. Yanagihara K, Takigahira M, Mihara K, Kubo T, Morimoto C, Morita Y, et al. Inhibitory effects of isoflavones on tumor growth and cachexia in newly established cachectic mouse models carrying human stomach cancers. Nutr Cancer 2013;65:578-89.
28. Fritz KL, Seppanen C, Kurzer MS, Saari Csallany A. The in vivo antioxidant activity of soybean isoflavones in human subjects. Nutr Res 2003;23:479-87.
29. Hämäläinen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-inflammatory effects of flavonoids: Genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007;2007:45673.
30. Brzezinski A, Debi A. Phytoestrogens: The “natural” selective estrogen receptor modulators? Eur J Obstet Gynecol Reprod Biol 1999;85:47-51.
31. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5.
32. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, et al. Genistein arrests cell cycle progression at G2-M. Cancer Res 1993;53:1328-31.
33. Tatsuta M, Iishi H, Baba M, Yano H, Uehara H, Nakaizumi A. Attenuation by genistein of sodium-chloride-enhanced gastric carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer 1999;80:396-9.
34. Cui HB, Na XL, Song DF, Liu Y. Blocking effects of genistein on cell proliferation and possible mechanism in human gastric carcinoma. World J Gastroenterol 2005;11:69-72.
35. Liu YL, Zhang GQ, Yang Y, Zhang CY, Fu RX, Yang YM. Genistein induces G2/M arrest in gastric cancer cells by increasing the tumor suppressor PTEN expression. Nutr Cancer 2013;65:1034-41.
36. Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q. Apoptosis of human primary gastric carcinoma cells induced by genistein. World J Gastroenterol 2004;10:1822-5.
37. Li YS, Wu LP, Li KH, Liu YP, Xiang R, Zhang SB, et al. Involvement of nuclear factor ?B (NF-?B) in the downregulation of cyclooxygenase-2 (COX-2) by genistein in gastric cancer cells. J Int Med Res 2011;39:2141-50.
38. Tang S, Hu J, Meng Q, Dong X, Wang K, Qi Y, et al. Daidzein induced apoptosis via down-regulation of Bcl-2/Bax and triggering of the mitochondrial pathway in BGC-823 cells. Cell Biochem Biophys 2013;65:197-202.